Piper Sandler adjusted its stance on Amphastar Pharmaceuticals (NASDAQ:AMPH), downgrading the company's stock rating from Overweight to Neutral and significantly reducing the price target to $36.00 ...

Susanne Lerche; Birgitte Brock; Jørgen Rungby; Hans E. Bøtker; Niels Møller; Anders Rodell; Bo Martin Bibby; Jens J. Holst; Ole Schmitz; Albert Gjedde ...

Please provide your email address to receive an email when new articles are posted on . The FDA has advised health care professionals that they should not use unapproved epinephrine nasal ...

Veiga-Fernandes and colleagues reported on their findings in Science, in a paper titled “Neuronal-ILC2 interactions regulate pancreatic glucagon and glucose homeostasis.” In their report the ...